Goldman Sachs Group Inc Amylyx Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,943,186 shares of AMLX stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,943,186
Previous 1,256,861
134.17%
Holding current value
$5.06 Million
Previous $18.5 Million
54.82%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMLX
# of Institutions
184Shares Held
50.3MCall Options Held
5.84MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA5.35MShares$9.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$7.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.47MShares$4.25 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$3.56 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$3.54 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $101M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...